Microtubule associated tumor suppressor 1 deficient mice develop spontaneous             heart hypertrophy and SLE-like lymphoproliferative disease.
The microtubule associated tumor suppressor gene 1 (MTUS1) is a recently published tumor suppressor gene, which has also been shown to act as an early component in the growth inhibitory signaling cascade of the angiotensin II type 2 receptor (AT2R). In this study we report the generation of MTUS1 knock-out (KO) mice, which develop normally but reveal higher body weights and slightly decreased blood pressure levels. Twenty-eight percent of the studied MTUS1 KO mice also developed heart hypertrophy and 12% developed nephritis, independent of blood pressure levels. Forty-three percent of the MTUS1 KO mice revealed lymphoid hyperplasia affecting spleen (20%), kidney (37%), lung (23%), lymph nodes (17%), and liver (17%) accompanied with leukocytosis, lymphocytosis, and mild anemia. One animal (3%) developed a marginal zone B-cell lymphoma affecting submandibular salivary gland and regional lymph nodes. The symptoms of all mentioned animals are consistent with a B-cell lymphoproliferative disease with features of systemic lupus erythematosus. In addition, body weight of the MTUS1 KO mice was significantly increased and isolated skin fibroblasts showed increased cell proliferation and decreased cell size, compared to wild-type (WT) fibroblasts in response to depleted FCS concentration and lack of growth factors. In conclusion we herein report the first generation of a MTUS1 KO mouse, developing spontaneous heart hypertrophy and increased cell proliferation, confirming once more the anti-proliferative effect of MTUS1, and a SLE-like lymphoproliferative disease suggesting crucial role in regulation of inflammation. These MTUS1 KO mice can therefore serve as a model for further investigations in cardiovascular disease, autoimmune disease and carcinogenesis.
Department of Nephrology and Hypertension, University of Erlangen-Nuernberg, Loschgestr 8, 91054 Erlangen, Germany. dr.christina.zuern@hotmail.de
Christina
C
Zuern
Laszlo
L
Krenacs
Stephanie
S
Starke
Jutta
J
Heimrich
Alois
A
Palmetshofer
Bettina
B
Holtmann
Michael
M
Sendtner
Tobias
T
Fischer
Jan
J
Galle
Christoph
C
Wanner
Stefan
S
Seibold
D000818:Animals; D006332:Cardiomegaly / Q000097:blood / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D002352:Carrier Proteins / Q000235:genetics; D048708:Cell Growth Processes / Q000502:physiology; D005347:Fibroblasts / Q000473:pathology; D007150:Immunohistochemistry; D018442:Lymphoma, B-Cell, Marginal Zone / Q000097:blood / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D008232:Lymphoproliferative Disorders / Q000097:blood / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D018345:Mice, Knockout; D012867:Skin / Q000473:pathology; D025521:Tumor Suppressor Proteins / Q000172:deficiency* / Q000235:genetics
D002352:Carrier Proteins; C488664:Mtus1 protein, mouse; D025521:Tumor Suppressor Proteins